Solubilities of Adenosine Antagonists Determined by Radioreceptor Assay
- 1 September 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 41 (9) , 590-594
- https://doi.org/10.1111/j.2042-7158.1989.tb06537.x
Abstract
The practical use of many adenosine receptor antagonists is limited by poor aqueous solubility. In some cases, solubilities are so low that they are difficult to measure by conventional means. To determine solubilities of adenosine antagonists, a sensitive radioreceptor method has been developed. Solubilities in Tris buffer (pH 7·7) ranged from 141 nM for 8−(2−amino−4−hlorophenyl)−1,3−dipropylxanthine to 945 μM for the amino-substituted xanthine PD 113,297. Ratios between solubility and adenosine receptor affinity varied from 15·8 for the A2-selective antagonist HTQZ to 169 000 for PD 113,297. From literature data on functional activity, it is apparent that useful adenosine antagonist activity in-vivo is only seen in compounds with solubility/affinity ratios greater than 100.This publication has 22 references indexed in Scilit:
- Pre‐and postjunctional actions of purine and xanthine compounds in the guinea‐pig caecum circular muscleBritish Journal of Pharmacology, 1988
- [1,2,4]Triazolo[4,3-a]quinoxalin-4-amines: a new class of A1 receptor selective adenosine antagonistsJournal of Medicinal Chemistry, 1988
- Evidence That a Novel 8-Phenyl-Substituted Xanthine Derivative is a Cardioselective Adenosine Receptor Antagonist In VivoJournal of Cardiovascular Pharmacology, 1987
- Regulation of adenosine formation by the heart.Circulation Research, 1986
- Functionalized congeners of 1,3-dialkylxanthines: preparation of analogs with high affinity for adenosine receptorsJournal of Medicinal Chemistry, 1985
- Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship applicationJournal of Medicinal Chemistry, 1985
- PACPX ‐ a substituted xanthine ‐ antagonizes both the A1 and A2 subclasses of the P1‐purinoceptor: antagonism of the A2 subclass is competitive but antagonism of the A1 subclass is notBritish Journal of Pharmacology, 1985
- Adenosine and the concept of ‘retaliatory metabolites’Trends in Biochemical Sciences, 1984
- Adenosine receptor binding: structure-activity analysis generates extremely potent xanthine antagonists.Proceedings of the National Academy of Sciences, 1983
- Adenosine antagonism by purines, pteridines and benzopteridines in human fibroblastsBiochemical Pharmacology, 1981